18 Recruiting Studies Using Plerixafor
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Plerixafor
Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Sickle Cell Anemia
View Study & Checklist ➔Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma
📍 City of Hope Medical Center — Duarte, California
Recurrent Grade 1 Follicular Lymphoma
View Study & Checklist ➔Safety of Blood Stem Cell Mobilization With Plerixafor in Patients With Sickle Cell Disease
📍 City of Hope Medical Center — Duarte, California
Sickle Cell Disease
View Study & Checklist ➔Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)
📍 University of Nebraska Medical Center — Omaha, Nebraska
Diffuse Large B-cell Lymphoma (DLBCL)
View Study & Checklist ➔Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
📍 Stanford University — Stanford, California
Allogeneic Hematopoietic Cell Transplantation (HCT)
View Study & Checklist ➔Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
WHIM
View Study & Checklist ➔Stem Cell Mobilization and Apheresis for Life-threatening Blood Disorders
📍 Saint Jude Children's Research Hospital — Memphis, Tennessee
Bone Marrow Failure Syndrome
View Study & Checklist ➔Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
HIV
View Study & Checklist ➔Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Idiopathic CD4-Positive
View Study & Checklist ➔Allo HSCT for High Risk Hemoglobinopathies
📍 Masonic Cancer Center — Minneapolis, Minnesota
Graft Failure
View Study & Checklist ➔Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma
📍 MD Anderson Cancer Center — Houston, Texas
Multiple Myeloma
View Study & Checklist ➔Mozobil for Autologous Hematopoietic Stem Cell Transplantation
📍 Thomas Jefferson University Hospital — Philadelphia, Pennsylvania
Multiple Myeloma
View Study & Checklist ➔Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder
📍 MD Anderson Cancer Center — Houston, Texas
RUNX1 Familial Platelet Disorder
View Study & Checklist ➔Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Chronic Granulomatous Disease (CGD)
View Study & Checklist ➔Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
📍 Alliance for Clinical Trials in Oncology — Chicago, Illinois
Plasma Cell Leukemia
View Study & Checklist ➔Gene Editing For Sickle Cell Disease
📍 St. Jude Children's Research Hospital — Memphis, Tennessee
Sickle Cell Disease
View Study & Checklist ➔Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML
📍 Washington University School of Medicine — St Louis, Missouri
AML, Childhood
View Study & Checklist ➔Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium
📍 Yale Fertility Center — Orange, Connecticut
Asherman Syndrome
View Study & Checklist ➔